HEADER TRANSCRIPTION 31-OCT-16 5M96 TITLE SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW TRIAZOLO AND TITLE 2 IMIDAZOLOPYRIDINE RORGT INVERSE AGONISTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, LIGAND BINDING DOMAIN, UNP RESIDUES 263- COMPND 5 491; COMPND 6 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 7 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 8 ORPHAN RECEPTOR-GAMMA; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS NUCLEAR HORMONE RECEPTOR, LIGAND-BINDING DOMAIN, INVERSE AGONIST, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 4 08-MAY-24 5M96 1 REMARK REVDAT 3 19-DEC-18 5M96 1 REMARK LINK SITE ATOM REVDAT 2 28-DEC-16 5M96 1 JRNL REVDAT 1 14-DEC-16 5M96 0 JRNL AUTH S.HINTERMANN,C.GUNTERMANN,H.MATTES,D.A.CARCACHE,J.WAGNER, JRNL AUTH 2 A.VULPETTI,A.BILLICH,J.DAWSON,K.KAUPMANN,J.KALLEN, JRNL AUTH 3 R.STRINGER,D.ORAIN JRNL TITL SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW TRIAZOLO- AND JRNL TITL 2 IMIDAZOLOPYRIDINE ROR GAMMA T INVERSE AGONISTS. JRNL REF CHEMMEDCHEM V. 11 2640 2016 JRNL REFN ESSN 1860-7187 JRNL PMID 27902884 JRNL DOI 10.1002/CMDC.201600500 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 60571 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3187 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3662 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 140 REMARK 3 SOLVENT ATOMS : 349 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.108 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.099 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.062 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5M96 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1200002115. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00003 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE REMARK 200 DATA SCALING SOFTWARE : XSCALE, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63761 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 19.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.20 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.20 REMARK 200 R MERGE FOR SHELL (I) : 0.90300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.75M NAFORMATE, 0.1M PIPES, PH 7.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.56200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 77.12400 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 57.84300 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 96.40500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 19.28100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 262 REMARK 465 PRO A 263 REMARK 465 TYR A 264 REMARK 465 HIS A 490 REMARK 465 PRO A 491 REMARK 465 GLY B 262 REMARK 465 PRO B 263 REMARK 465 TYR B 264 REMARK 465 HIS B 488 REMARK 465 LEU B 489 REMARK 465 HIS B 490 REMARK 465 PRO B 491 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 435 62.65 -115.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y B 502 DBREF 5M96 A 263 491 UNP P51449 RORG_HUMAN 263 491 DBREF 5M96 B 263 491 UNP P51449 RORG_HUMAN 263 491 SEQADV 5M96 GLY A 262 UNP P51449 EXPRESSION TAG SEQADV 5M96 SER A 455 UNP P51449 CYS 455 ENGINEERED MUTATION SEQADV 5M96 GLY B 262 UNP P51449 EXPRESSION TAG SEQADV 5M96 SER B 455 UNP P51449 CYS 455 ENGINEERED MUTATION SEQRES 1 A 230 GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL SEQRES 2 A 230 GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU SEQRES 3 A 230 ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SEQRES 4 A 230 SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET SEQRES 5 A 230 TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU SEQRES 6 A 230 ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER SEQRES 7 A 230 GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU SEQRES 8 A 230 LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET SEQRES 9 A 230 CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE SEQRES 10 A 230 GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU SEQRES 11 A 230 GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER SEQRES 12 A 230 HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE SEQRES 13 A 230 ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG SEQRES 14 A 230 PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN SEQRES 15 A 230 TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS SEQRES 16 A 230 THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS SEQRES 17 A 230 GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG SEQRES 18 A 230 LEU GLN ILE PHE GLN HIS LEU HIS PRO SEQRES 1 B 230 GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL SEQRES 2 B 230 GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU SEQRES 3 B 230 ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SEQRES 4 B 230 SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET SEQRES 5 B 230 TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU SEQRES 6 B 230 ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER SEQRES 7 B 230 GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU SEQRES 8 B 230 LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET SEQRES 9 B 230 CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE SEQRES 10 B 230 GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU SEQRES 11 B 230 GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER SEQRES 12 B 230 HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE SEQRES 13 B 230 ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG SEQRES 14 B 230 PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN SEQRES 15 B 230 TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS SEQRES 16 B 230 THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS SEQRES 17 B 230 GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG SEQRES 18 B 230 LEU GLN ILE PHE GLN HIS LEU HIS PRO HET Q6Y A 501 35 HET Q6Y A 502 35 HET Q6Y B 501 35 HET Q6Y B 502 35 HETNAM Q6Y ~{N}-[8-[[(3~{S})-4-CYCLOPENTYLCARBONYL-3-METHYL- HETNAM 2 Q6Y PIPERAZIN-1-YL]METHYL]-7-METHYL-IMIDAZO[1,2-A]PYRIDIN- HETNAM 3 Q6Y 6-YL]-2-METHYL-PYRIMIDINE-5-CARBOXAMIDE FORMUL 3 Q6Y 4(C26 H33 N7 O2) FORMUL 7 HOH *349(H2 O) HELIX 1 AA1 SER A 266 GLU A 283 1 18 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 LYS A 311 1 11 HELIX 5 AA5 SER A 312 LEU A 338 1 27 HELIX 6 AA6 GLY A 340 LEU A 344 5 5 HELIX 7 AA7 CYS A 345 MET A 365 1 21 HELIX 8 AA8 GLY A 384 GLY A 392 5 9 HELIX 9 AA9 CYS A 393 ALA A 409 1 17 HELIX 10 AB1 SER A 413 ILE A 426 1 14 HELIX 11 AB2 GLU A 435 THR A 457 1 23 HELIX 12 AB3 ARG A 459 LEU A 466 5 8 HELIX 13 AB4 PRO A 468 LEU A 489 1 22 HELIX 14 AB5 SER B 266 THR B 284 1 19 HELIX 15 AB6 ARG B 288 GLN B 295 1 8 HELIX 16 AB7 ARG B 296 ASN B 298 5 3 HELIX 17 AB8 SER B 301 LYS B 311 1 11 HELIX 18 AB9 SER B 312 ARG B 337 1 26 HELIX 19 AC1 LEU B 338 GLU B 343 1 6 HELIX 20 AC2 CYS B 345 MET B 365 1 21 HELIX 21 AC3 GLY B 384 GLY B 392 5 9 HELIX 22 AC4 CYS B 393 LEU B 410 1 18 HELIX 23 AC5 SER B 413 ILE B 426 1 14 HELIX 24 AC6 GLU B 435 THR B 457 1 23 HELIX 25 AC7 ARG B 459 LEU B 466 5 8 HELIX 26 AC8 GLY B 470 GLN B 487 1 18 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O GLY A 383 N VAL A 376 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 SITE 1 AC1 16 CYS A 320 HIS A 323 LEU A 324 MET A 365 SITE 2 AC1 16 ALA A 368 VAL A 376 PHE A 377 PHE A 378 SITE 3 AC1 16 ILE A 400 PHE A 401 SER A 404 HIS A 479 SITE 4 AC1 16 PHE A 486 HOH A 653 HOH A 708 HOH A 711 SITE 1 AC2 12 THR A 325 ILE A 328 GLN A 329 GLU A 333 SITE 2 AC2 12 LYS A 354 MET A 358 HOH A 657 GLN B 346 SITE 3 AC2 12 ILE B 350 LEU B 353 Q6Y B 502 HOH B 663 SITE 1 AC3 16 CYS B 320 HIS B 323 LEU B 324 MET B 365 SITE 2 AC3 16 ALA B 368 VAL B 376 PHE B 377 LEU B 396 SITE 3 AC3 16 ILE B 397 ILE B 400 PHE B 401 SER B 404 SITE 4 AC3 16 HIS B 479 HOH B 629 HOH B 686 HOH B 689 SITE 1 AC4 11 THR A 325 ILE A 328 GLN A 329 VAL A 332 SITE 2 AC4 11 LEU A 353 Q6Y A 502 HOH A 657 VAL B 332 SITE 3 AC4 11 GLN B 346 ILE B 350 LYS B 354 CRYST1 100.017 100.017 115.686 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009998 0.005773 0.000000 0.00000 SCALE2 0.000000 0.011545 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008644 0.00000